Scientists at The Wistar Institute have unveiled part of the protein complex that protects telomeres—the ends of our chromosomes.
10-Apr-2017 10:05 AM EDT Add to Favorites
The Wistar Institute Appoints Farokh Dotiwala, M.B.B.S., Ph.D., as Assistant Professor in the Vaccine Center
Antibiotic-resistant strains of bacteria like Mycobacterium tuberculosis and Staphylococcus and pathogens like malaria are emerging throughout the world. Dotiwala’s research centers on the mechanisms of killer immune cells—such as natural killer...
27-Mar-2017 9:05 AM EDT Add to Favorites
The Wistar Institute Appoints Mohamed Abdel-Mohsen, Ph.D., as Assistant Professor in the Vaccine Center
The Wistar Institute announces the appointment of Mohamed Abdel-Mohsen, Ph.D., as assistant professor in Wistar’s Vaccine Center.
15-Mar-2017 11:05 AM EDT Add to Favorites
Wistar scientists have secured more than $4,720,000 million in research funds.
13-Mar-2017 9:05 AM EDT Add to Favorites
Philadelphia Research Consortium Launched to Speed Access to Preclinical Research Capabilities Across Philadelphia’s Life Sciences Community
The Wistar Institute, together with many regional academic institutions driving life sciences discoveries, has launched the Philadelphia Research Consortium – a preclinical research network for facilitating easy access to our region’s robust...
1-Mar-2017 10:30 AM EST Add to Favorites
Genetic Variant of the p53 Gene Linked to Breast Cancer Risk in Premenopausal African American Women
Scientists at The Wistar Institute in collaboration with Roswell Park Cancer Institute found a significant association between a rare genetic variant of the p53 gene present in African American women and their risk of developing breast cancer in...
27-Feb-2017 8:05 AM EST Add to Favorites
Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc. have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important cancer antigen targets.
24-Feb-2017 11:05 AM EST Add to Favorites
Wistar scientists have shown an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression and resistance to targeted therapies for the...
22-Feb-2017 1:00 PM EST Add to Favorites
Dr. Luis Montaner, Wistar Institute HIV/AIDS Expert, Can Address His Work in the Search for a Cure, for World AIDS Day
26-Nov-2013 2:25 PM EST
22-Feb-2013 4:15 PM EST
The Winter Sun May Not Be Warm, but Still Can Be Dangerous. Wistar Melanoma Expert on Wintertime UV Risks
22-Jan-2013 2:30 PM EST